diaMentis Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 14

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 2

diaMentis General Information

Description

Developer of software as a medical device designed to analyze information from a simple examination of the eye. The company's device helps to aid in the diagnosis of mental health disorders based on electroretinography (ERG) and improves patient care, enabling clinicians to make a faster, more objective and accurate diagnosis of mental health disorders in a personalized healthcare environment.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2875 Laurier Boulevard
  • Suite D1-1100
  • Quebec, Quebec G1V 2M2
  • Canada
+1 (418)
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Other Healthcare Technology Systems
Vertical(s)
Corporate Office
  • 2875 Laurier Boulevard
  • Suite D1-1100
  • Quebec, Quebec G1V 2M2
  • Canada
+1 (418)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

diaMentis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Accelerator/Incubator 01-Oct-2025 Completed Generating Revenue
2. Seed Round Completed Generating Revenue
1. Grant 31-May-2016 $350K Completed Generating Revenue
To view diaMentis’s complete valuation and funding history, request access »

diaMentis Patents

diaMentis Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023219254-A1 Systems and methods for retinal stimulation and/or collecting retinal signal data Pending 09-Feb-2022
EP-4475740-A1 Systems and methods for retinal stimulation and/or collecting retinal signal data Pending 09-Feb-2022
EP-4475740-A4 Systems and methods for retinal stimulation and/or collecting retinal signal data Pending 09-Feb-2022
US-12521013-B2 Systems and methods for retinal stimulation and/or collecting retinal signal data Active 09-Feb-2022
US-20230248237-A1 Systems and methods for retinal stimulation and/or collecting retinal signal data Active 09-Feb-2022 A61B5/398
To view diaMentis’s complete patent history, request access »

diaMentis Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

diaMentis Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
3DEXPERIENCE Lab Accelerator/Incubator
National Research Council Canada Government
To view diaMentis’s complete investors history, request access »

diaMentis FAQs

  • When was diaMentis founded?

    diaMentis was founded in 2015.

  • Where is diaMentis headquartered?

    diaMentis is headquartered in Quebec, Canada.

  • What is the size of diaMentis?

    diaMentis has 14 total employees.

  • What industry is diaMentis in?

    diaMentis’s primary industry is Diagnostic Equipment.

  • Is diaMentis a private or public company?

    diaMentis is a Private company.

  • What is diaMentis’s current revenue?

    The current revenue for diaMentis is .

  • Who are diaMentis’s investors?

    3DEXPERIENCE Lab and National Research Council Canada have invested in diaMentis.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process